Form4insider filings, from the source

SEC Form 4 · accession 0001562180-17-002422

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Brenda S. Furlow
Officer — SVP - General Counsel
Period of report
Jul 1, 2017
Accepted (ET)
Jul 5, 2017 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 1, 2017F278$117.50D1,668D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F2—holding—————Common Stock1,2001,200D
Restricted Stock UnitsF3,F4—holding—————Common Stock1,7591,759D
Stock Option (Right to Buy)F5$108.49holding————Aug 7, 2022Common Stock10,00010,000D
Stock Option (Right to Buy)F2$108.49holding————Aug 7, 2022Common Stock7,5007,500D
Stock Option (Right to Buy)F6$94.35holding————Aug 12, 2021Common Stock15,00015,000D
Stock Options (Right to buy)F7$106.59holding————Aug 18, 2023Common Stock14,47614,476D
Stock Options (Right to buy)F4$106.59holding————Aug 18, 2023Common Stock10,85710,857D

Explanation of responses